MAPK1 and Miyoshi myopathy: The confirmation of the DMKN-ERK interaction in the ERK-MAPK kinase signaling necessitates a purposeful proof-of-principle model to study the naturally-occurring p.E69D and p.V91A DMKN mutations which may be associated with an alternative genetic basis for the manipulation to trigger the EMT and MM.